Search Results - Xiaoqian Xu

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20-45 years of age by Tianmeng Wen, Xiaoqian Xu, Chenghao Pan, Shangying Hu, Huan Zhao, Xun Zhang, Youlin Qiao, Fanghui Zhao

Connect to this object online.

Relationship Between Outdoor Air Pollutant Exposure and Premature Delivery in China- Systematic Review and Meta-Analysis by Xue Wang, Xin Wang, Chenghua Gao, Xiaoqian Xu, Lehui Li, Yan Liu, Zichao Li, Yuan Xia, Xin Fang

Connect to this object online.

Assessment of cardiovascular disease risk in Northern China: a cross-sectional study by Hao Zhu, Yunfeng Xi, Han Bao, Xiaoqian Xu, Liwei Niu, Yan Tao, Ning Cao, Wenrui Wang, Xingguang Zhang

Connect to this object online.

An Assessment of the Predictive Performance of Current Machine Learning-Based Breast Cancer Risk Prediction Models: Systematic Review by Ying Gao, Shu Li, Yujing Jin, Lengxiao Zhou, Shaomei Sun, Xiaoqian Xu, Shuqian Li, Hongxi Yang, Qing Zhang, Yaogang Wang

Connect to this object online.

Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in northern China: a cross-sectional study by Yunfeng Xi, Liwei Niu, Ning Cao, Han Bao, Xiaoqian Xu, Hao Zhu, Tao Yan, Nan Zhang, Liying Qiao, Ke Han, Gai Hang, Wenrui Wang, Xingguang Zhang

Connect to this object online.

Self-reported hypertension in Northern China: a cross-sectional study of a risk prediction model and age trends by Maolin Du, Shaohua Yin, Peiyu Wang, Xuemei Wang, Jing Wu, Mingming Xue, Huiqiu Zheng, Yajun Zhang, Danyan Liang, Ruiqi Wang, Dan Liu, Wei Shu, Xiaoqian Xu, Ruiqi Hao, Shiyuan Li

Connect to this object online.

Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study by Changfa Xia, MPH, Shangying Hu, PhD, Xiaoqian Xu, MPH, Xuelian Zhao, MPH, Youlin Qiao, ProfPhD, Nathalie Broutet, PhD, Karen Canfell, ProfDPhil, Raymond Hutubessy, PhD, Fanghui Zhao, ProfPhD

Connect to this object online.

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial by Shangying Hu, Xiaoqian Xu, Fengcai Zhu, Ying Hong, Yuemei Hu, Xun Zhang, Qinjing Pan, Wenhua Zhang, Chengfu Zhang, Xiaoping Yang, Jiaxi Yu, Jiahong Zhu, Yejiang Zhu, Feng Chen, Shuang Zhao, Naveen Karkada, Haiwen Tang, Dan Bi, Frank Struyf, Fanghui Zhao

Connect to this object online.